IL1B and breast cancer: IL1β expression correlates with increased aggressiveness and enhanced metastatic potential of BC cells, suggesting IL-1β as a potential biomarker for predicting which patients are likely to be diagnosed with BC metastasis, specifically to bone (Tulotta et al., 2019).